iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionWestside Investment Management, Inc.
Latest Disclosed Ownership18,326 shares
Latest Disclosed Value $ 3,095,244
Westside Investment Management, Inc. reports 1.98% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 4, 2026 - Westside Investment Management, Inc. filed a 13F-HR form disclosing ownership of 18,326 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $3,095,244 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 17,970 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 1.98% during the quarter. The current value of the position is $2,401,622 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F ISHARES BIOTECHNOLOGY ETF 464287556 18,326 356 1.98 3,095 2.04 0.2307
2026-01-23 2025-12-31 13F ISHARES BIOTECHNOLOGY ETF 464287556 17,970 87 0.49 3,033 17.33 0.4852
2025-11-04 2025-09-30 13F ISHARES BIOTECHNOLOGY ETF 464287556 17,883 -665 -3.59 2,586 10.14 0.4131
2025-08-05 2025-06-30 13F ISHARES BIOTECHNOLOGY ETF 464287556 18,548 118 0.64 2,348 -0.25 0.4354
2025-04-25 2025-03-31 13F ISHARES BIOTECHNOLOGY ETF 464287556 18,430 1,478 8.72 2,354 5.00 0.5014
2025-01-17 2024-12-31 13F ISHACOM BIOTECHNOLOGY ETF 464287556 16,952 -50 -0.29 2,241 -9.53 0.4723
2024-11-20 2024-09-30 13F ISHARES BIOTECHNOLOGY ETF 464287556 17,002 204 1.21 2,477 7.46 0.5275
2024-07-17 2024-06-30 13F ISHARES BIOTECHNOLOGY ETF 464287556 16,798 2,700 19.15 2,306 19.18 0.5277
2024-04-19 2024-03-31 13F ISHARES BIOTECHNOLOGY ETF 464287556 14,098 750 5.62 1,934 6.67 0.4636
2024-01-12 2023-12-31 13F ISHARES BIOTECHNOLOGY ETF 464287556 13,348 2,502 23.07 1,813 36.73 0.4637
2023-11-15 2023-09-30 13F ISHARES BIOTECHNOLOGY ETF 464287556 10,846 127 1.18 1,326 -2.50 0.3819
2023-07-14 2023-06-30 13F ISHARES BIOTECHNOLOGY ETF 464287556 10,719 -1,374 -11.36 1,361 -12.88 0.3843
2023-05-17 2023-03-31 13F ISHARES BIOTECHNOLOGY ETF 464287556 12,093 341 2.90 1,562 156,000.00 0.4586
2023-01-31 2022-12-31 13F ISHARES BIOTECHNOLOGY ETF 464287556 11,752 -678 -5.45 2 -98.59 0.0038
2022-11-09 2022-09-30 13F ISHARES BIOTECHNOLOGY ETF 464287556 12,430 52 0.42 72 -12.35 0.1710
2022-07-15 2022-06-30 13F ISHARES BIOTECHNOLOGY ETF 464287556 12,378 125 1.02 81 0.00 0.1838
2022-04-25 2022-03-31 13F ISHARES BIOTECHNOLOGY ETF 464287556 12,253 782 6.82 81 24.62 0.1786
2022-02-15 2021-12-31 13F ISHARES BIOTECHNOLOGY ETF UIT 464287556 11,471 451 4.09 65 0.00 0.1488
2021-10-27 2021-09-30 13F ISHARES BIOTECHNOLOGY ETF ETF 464287556 11,020 -79 -0.71 65 -2.99 0.1505
2021-07-28 2021-06-30 13F ISHARES BIOTECHNOLOGY ETF UIT 464287556 11,099 150 1.37 67 9.84 0.1558
2021-04-14 2021-03-31 13F ISHARES NASDAQ UIT 464287556 10,949 922 9.20 62 6,000.00 0.1631
2021-01-15 2020-12-31 13F ISHARES NASDAQ ETF 464287556 10,027 721 7.75 2 0.00 0.0042
2020-10-14 2020-09-30 13F ISHARES NASDAQ ETF 464287556 9,306 0 0.00 1 0.00 0.0006
2020-07-21 2020-06-30 13F ISHARES NASDAQ ETF 464287556 9,306 -58 -0.62 1 0.00 0.0007
2020-04-16 2020-03-31 13F ISHARES NASDAQ ETF 464287556 9,364 503 5.68 1 4.35 0.0007
2019-07-24 2019-06-30 13F ISHARES NASDAQ ETF 464287556 8,861 3,846 76.69 1 -100.00 0.0021
2019-02-05 2018-12-31 13F ISHARES NASDAQ ETF 464287556 5,015 165 3.40 484 -17.72 0.1771
2018-11-08 2018-09-30 13F ISHARES NASDAQ ETF 464287556 4,850 -400 -7.62 588 1.03 0.1879
2018-08-13 2018-06-30 13F ISHARES NASDAQ ETF 464287556 5,250 100 1.94 581 10.25 0.2045
2018-04-16 2018-03-31 13F ISHARES NASDAQ BIOTECH ETF 464287556 5,150 -175 -3.29 528 -8.67 0.2901
2018-02-15 2017-12-31 13F ISHARES NASDAQ BIOTECH ETF 464287556 5,325 3,495 190.98 577 -7.09 0.3126
2017-11-13 2017-09-30 13F ISHARES NASDAQ ETF 464287556 1,830 0 0.00 621 9.52 0.3750
2017-09-14 2017-06-30 13F/A-1 ISHARES NASDAQ ETF 464287556 1,830 0 0.00 567 8.00 0.3701
2017-08-15 2017-06-30 13F ISHARES NASDAQ BIOTECH ETF 464287556 10,994 9,164 870
2017-05-11 2017-03-31 13F ISHARES NASDAQ BIOTECH ETF 464287556 1,830 620 51.24 526 56.25 0.2512
2017-05-11 2016-12-31 13F ISHARES NASDAQ ETF 464287556 1,210 1,210 336 0.2288
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.